Severe, long-standing DME with cystoid changes, subretinal detachment, and high inflammatory cytokine burden tends to respond better to dual ANG2/VEGF-A inhibition than VEGF monotherapy. Faricimab ...
PARIS – Pneumatic displacement of submacular hemorrhage by subretinal injection of recombinant tissue plasminogen activator was effective in restoring visual function in a series of age-related ...
To assess the efficacy of small-gauge vitrectomy with subretinal recombinant tissue plasminogen activator (rtPA) and ranibizumab for submacular haemorrhages secondary to neovascular age-related ...
“Currently, there is a lack of evidence-based research and rigorous guidelines for the management of patients with SMH secondary to nAMD [neovascular AMD],” said Dr. Gabrielle, who is based at the ...
NEW ORLEANS — Gene therapy with a vascular endothelial growth-factor (VEGF)-binding protein for wet age-related macular degeneration has shown biologic activity and safety in early-phase trials. "The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results